P-cadherin overexpression is associated with early transformation of the Fallopian tube epithelium and aggressiveness of tubo-ovarian high-grade serous carcinoma
Tubo-ovarian high-grade serous carcinoma (HGSC) with proficient homologous recombination (HR) DNA repair (HRP) accounts for approximately 50% of cases and is associated with platinum-resistance and poor prognosis. We hypothesize that the acquisition of hybrid phenotypes displaying both epithelial and mesenchymal (E/M) features may be involved in the malignant transformation and tumour dissemination in this subgroup. Therefore, we analysed, by digital pathology, the expression and prognostic significance of 3 classic cadherins (E-cadherin, epithelial marker; N-cadherin, mesenchymal marker; and P-cadherin, candidate marker of hybrid E/M) in 577 formalin-fixed paraffin-embedded human samples representing the putative stepwise serous carcinogenesis in the Fallopian tube epithelium (FTE). We observed a non-canonical N-to-P-cadherin switch along the carcinogenic progression, with a statistically significant overexpression of P-cadherin in pre-malignant and malignant samples, compared to the control FTE. Interestingly, this overexpression was most pronounced in precursor lesions and HGSC cells from malignant ascites. Tumours with high P-cadherin expression were significantly associated with worse overall survival, especially in the subgroup without BRCA1/2 mutations. Transient P-cadherin knock-down resulted in in vitro significant reduction of functional hybrid E/M hallmarks, namely decreased anoikis resistance, reduced collective migration and invasion in a representative platinum-resistant HRP cell line. Taken together, our results suggest that P-cadherin overexpression is an early event in the serous carcinogenesis and may be involved in hybrid E/M activation in HRP-HGSC, further supporting this adhesion molecule as a promising biomarker for this poor prognostic subgroup.
Authors
- Ricardo Coelho (ORCID: https://orcid.org/0000-0002-9340-3612)
- Paula Monteiro (ORCID: https://orcid.org/0000-0002-3482-2307)
- R. Canário (ORCID: https://orcid.org/0000-0002-3563-7752)
- Francis Jacob (ORCID: https://orcid.org/0000-0002-0446-1942)
- Nuno Mendes (ORCID: https://orcid.org/0000-0002-0570-2277)
- Carla Bartosch (ORCID: https://orcid.org/0000-0003-0646-7667)
- Joana Paredes (ORCID: https://orcid.org/0000-0002-1076-1343)
- Manuel R. Teixeira (ORCID: https://orcid.org/0000-0002-4896-5982)
- Ana Sofia Ribeiro (ORCID: https://orcid.org/0000-0002-9698-9233)
- Sara Ricardo (ORCID: https://orcid.org/0000-0003-4091-2226)
- Viola A Heinzelmann-Schwarz (ORCID: https://orcid.org/0000-0002-5613-8629)
- Inês Morgado (ORCID: https://orcid.org/0000-0003-0938-455X)
- Catarina Santos (ORCID: https://orcid.org/0000-0002-9102-757X)
- Ana Peixoto (ORCID: https://orcid.org/0000-0002-1404-5897)
- Ana Paula Fernandes Barbosa (ORCID: https://orcid.org/0000-0002-2307-1018)
- Pamella Glória Rodrigues da Penha LOPES (ORCID: https://orcid.org/0000-0003-0633-4143)
Institutions
- Universidade do Porto (PT)
- University of Basel (CH)
- University Hospital of Basel (CH)
- Cooperativa de Ensino Superior Politécnico e Universitário (PT)
- Instituto Português de Oncologia Francisco Gentil (PT)
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT)
Publication Details
- Journal
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
- Published
- 2025-05-04
- DOI
- https://doi.org/10.1007/s00428-025-04104-7
- Primary Topic
- Wnt/β-catenin signaling in development and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidade do Porto